Ophthalmology Technology Summit 2019 Poised to Foster New Breakthroughs and Valuable Collaborations

ALISO VIEJO, Calif.- OCTANe, Orange County’s technology and life sciences accelerator organization, today announced it has chosen four LaunchPad SBDC companies to present at this year’s sixth annual Ophthalmology Technology Summit on June 28th at the Fashion Island Hotel. The four companies include: Cell Care Therapeutics, IACTA, Visgenx, and Lentechs.

OCTANe is also excited to announce that for the second year in a row, they have partnered with CEDARS/ASPENS. The CEDARS/ASPENS collaboration with OCTANe will lead to several key opinion leaders receiving the most current and future technologies from industry to better our surgical and medical outcomes in the ophthalmic field.

“OTS 2019 will highlight why SoCal and specifically Orange County is the epicenter of innovation for this dynamic industry. During OTS attendees will have the opportunity to learn more about OCTANe's impact on this industry and the overall SoCal ecosystem by highlighting unique discussions on innovation, investment and business effectiveness. It is the place for industry leaders, physicians and entrepreneurs to convene and share ideas. Of special interest will be 4 companies that have completed our LaunchPad accelerator and are ready for investment along with our partner, Visionary Ventures who will hold their annual investor meeting”, said OCTANe CEO, Bill Carpou.

OTS provides an intensive one-day forum that showcases new innovations and fosters partnerships between physicians, entrepreneurs, investors and business entities that share a passion to advance ophthalmology through technology. Events at OTS 2019 will focus on groundbreaking ophthalmic technologies, unmet clinical needs and new business opportunities.

Highlights of the agenda include:

  • This year, the conference will be moderated by Tom Mitro, President & COO, Aerie Pharmaceuticals
  • A keynote interview with Glaukos CEO Tom Burns
  • A lineup of ophthalmology’s key opinion leaders, including Jim Mazzo, John Hovanesian, MD, FACS, Ehsan Sadri, MD, FACS, Elizabeth Yeu, MD, Richard Lindstrom, MD, and Tom Frinzi
  • Featured guest speakers Bradford and Bryan Manning, Co-Founders, Two Blind Brothers, as well as Jason Menzo, COO, Foundation Fighting Blindness
  • Hear updates from OCTANe’s partner fund, Visionary Ventures
Details and registration are available at https://octaneoc.org/ophthalmology-technology-summit/.

About OCTANe

OCTANe is building the SoCal of Tomorrow by connecting people, resources and capital to fuel technology growth in Southern California. Its members represent technology executive leaders, entrepreneurs, investors, venture capitalists, academicians, and strategic advisors, all working together to fuel innovation in the OC. The organization has helped more than 800 companies via the LaunchPad SBDC accelerator. LaunchPad companies have received more than $2.1 billion in investment and equity exits. OCTANe annually welcomes more than 7,000 people to its programs and events. More than 2,000 business leaders throughout the region are OCTANe members. For more information, visit www.octaneoc.org.